0341 GMT - Life360 has the flexibility to manage potential dilution from its convertible note offering, MS analysts say. They tell clients that the tracking-app provider's raise strengthens its balance sheet through to fiscal 2030 at a very attractive rate. The trade-off is potential dilution if the dual-listed company's U.S. stock passes US$122.22 a share. They think that the structure of the notes and the strength of performance that would be required for the stock to trade at such levels provide Life360 with options to manage the scenario. MS has an overweight recommendation and A$32.00 target price on Life360's Australia-listed shares, which are down 1.7% at A$32.675. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
June 09, 2025 23:41 ET (03:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.